$1.15 Billion is the total value of GREAT POINT PARTNERS LLC's 37 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 87.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $138,820,000 | +45.0% | 5,015,175 | -4.7% | 12.09% | +37.4% |
| ZYME | Sell | ZYMEWORKS INC | $101,093,000 | +65.3% | 2,223,789 | -9.8% | 8.80% | +56.6% |
| PTCT | Sell | PTC THERAPEUTICS INC | $84,053,000 | +24.3% | 1,750,000 | -12.5% | 7.32% | +17.8% |
| AXSM | Buy | AXSOME THERAPEUTICS INCcall | $75,163,000 | +1756.8% | 727,200 | +263.6% | 6.54% | +1659.4% |
| NXTC | New | NEXTCURE INC | $63,911,000 | – | 1,134,584 | +100.0% | 5.56% | – |
| TGTX | New | TG THERAPEUTICS INC | $60,326,000 | – | 5,434,783 | +100.0% | 5.25% | – |
| SAGE | New | SAGE THERAPEUTICS INC | $57,467,000 | – | 796,057 | +100.0% | 5.00% | – |
| MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $55,055,000 | +324.8% | 2,790,400 | +179.0% | 4.79% | +302.9% |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $53,475,000 | -32.2% | 1,250,000 | -42.9% | 4.66% | -35.7% |
| CNST | New | CONSTELLATION PHARMCETICLS I | $53,476,000 | – | 1,135,122 | +100.0% | 4.66% | – |
| XLRN | Sell | ACCELERON PHARMA INC | $53,020,000 | -7.8% | 1,000,000 | -31.3% | 4.62% | -12.6% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $47,667,000 | +27.2% | 541,179 | +15.1% | 4.15% | +20.6% |
| DERM | DERMIRA INC | $39,739,000 | +137.2% | 2,621,333 | 0.0% | 3.46% | +124.8% | |
| PRTA | Buy | PROTHENA CORP PLC | $33,258,000 | +105.3% | 2,100,941 | +1.7% | 2.90% | +94.6% |
| ABEO | Buy | ABEONA THERAPEUTICS INC | $23,587,000 | +222.6% | 7,213,012 | +122.9% | 2.05% | +205.7% |
| ARVN | New | ARVINAS INC | $22,600,000 | – | 550,000 | +100.0% | 1.97% | – |
| ZGNX | Sell | ZOGENIX INC | $21,895,000 | -72.7% | 420,000 | -79.0% | 1.91% | -74.1% |
| AUPH | New | AURINIA PHARMACEUTICALS INCcall | $20,260,000 | – | 1,000,000 | +100.0% | 1.76% | – |
| TNDM | TANDEM DIABETES CARE INC | $14,903,000 | +1.1% | 250,000 | 0.0% | 1.30% | -4.1% | |
| GWPH | New | GW PHARMACEUTICALS PLCads | $14,814,000 | – | 141,683 | +100.0% | 1.29% | – |
| ZGNX | ZOGENIX INCcall | $13,033,000 | +30.2% | 250,000 | 0.0% | 1.14% | +23.5% | |
| AXNX | New | AXONICS MODULATION TECH INC | $12,927,000 | – | 466,507 | +100.0% | 1.13% | – |
| KURA | Sell | KURA ONCOLOGY INC | $11,739,000 | -74.9% | 853,777 | -72.3% | 1.02% | -76.2% |
| MLND | Buy | MILLENDO THERAPEUTICS INC | $11,659,000 | +27.3% | 1,729,759 | +34.3% | 1.02% | +20.7% |
| MTEM | New | MOLECULAR TEMPLATES INC | $11,538,000 | – | 825,000 | +100.0% | 1.00% | – |
| OPTN | New | OPTINOSE INC | $10,897,000 | – | 1,181,834 | +100.0% | 0.95% | – |
| MNLO | MENLO THERAPEUTICS INC | $7,665,000 | +3.6% | 1,652,013 | 0.0% | 0.67% | -1.9% | |
| VRAY | New | VIEWRAY INC | $7,238,000 | – | 1,715,153 | +100.0% | 0.63% | – |
| DXCM | Sell | DEXCOM INC | $5,709,000 | -74.7% | 26,100 | -82.7% | 0.50% | -76.0% |
| LQDA | New | LIQUIDIA TECHNOLOGIES INC | $5,463,000 | – | 1,277,955 | +100.0% | 0.48% | – |
| GNFT | Sell | GENFIT S Aads | $4,135,000 | -65.4% | 207,766 | -69.7% | 0.36% | -67.2% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $3,927,000 | -75.7% | 65,000 | -75.9% | 0.34% | -77.0% |
| BBIO | New | BRIDGEBIO PHARMA INC | $2,748,000 | – | 78,400 | +100.0% | 0.24% | – |
| INSM | New | INSMED INC | $2,325,000 | – | 97,359 | +100.0% | 0.20% | – |
| CYTK | New | CYTOKINETICS INC | $1,698,000 | – | 160,073 | +100.0% | 0.15% | – |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $1,153,000 | -83.7% | 70,000 | -86.0% | 0.10% | -84.6% |
| AXSM | New | AXSOME THERAPEUTICS INC | $26,000 | – | 254 | +100.0% | 0.00% | – |
| STRM | Exit | STREAMLINE HEALTH SOLUTNS, INC | $0 | – | -130,137 | -100.0% | -0.01% | – |
| OPK | Exit | OPKO HEALTH INC | $0 | – | -92,140 | -100.0% | -0.02% | – |
| MYOV | Exit | MYOVANT SCIENCES LTD | $0 | – | -325,000 | -100.0% | -0.16% | – |
| PTI | Exit | PROTEOSTASIS THERAPEUTICS INC. | $0 | – | -3,500,000 | -100.0% | -0.27% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS, INCcall | $0 | – | -200,000 | -100.0% | -0.33% | – |
| EXEL | Exit | EXELIXIS, INC | $0 | – | -309,700 | -100.0% | -0.50% | – |
| TPTX | Exit | TURNING POINT THERAPEUTICS, INC. | $0 | – | -222,222 | -100.0% | -0.77% | – |
| SILK | Exit | SILK ROAD MEDICAL INC | $0 | – | -301,979 | -100.0% | -0.90% | – |
| ALLK | Exit | ALLAKOS, INC. | $0 | – | -125,000 | -100.0% | -0.90% | – |
| MRTX | Exit | Mirati Therapeutics, Inc.call | $0 | – | -175,000 | -100.0% | -1.25% | – |
| TCDA | Exit | TRICIDA, INC. | $0 | – | -586,929 | -100.0% | -1.66% | – |
| RTRX | Exit | RETROPHIN INC | $0 | – | -1,740,000 | -100.0% | -1.85% | – |
| MRTX | Exit | Mirati Therapeutics, Inc.put | $0 | – | -300,000 | -100.0% | -2.15% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -300,000 | -100.0% | -2.15% | – |
| ASND | Exit | ASCENDIS PHARMA ASsponsored adr | $0 | – | -300,000 | -100.0% | -2.65% | – |
| ASND | Exit | ASCENDIS PHARMA AScall | $0 | – | -400,000 | -100.0% | -3.54% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -2,125,000 | -100.0% | -3.56% | – |
| PEN | Exit | PENUMBRA INC | $0 | – | -300,000 | -100.0% | -3.71% | – |
| MDCO | Exit | The Medicines Companycall | $0 | – | -1,000,000 | -100.0% | -4.59% | – |
| BOLD | Exit | AUDENTES THERAPEUTICS, INC. | $0 | – | -2,485,000 | -100.0% | -6.41% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STREAMLINE HEALTH SOLUTNS, INC CMN | 25 | Q3 2019 | 2.5% |
| IOVANCE BIOTHERAPEUTICS, INC. CMN | 16 | Q1 2021 | 14.3% |
| ZOGENIX INC CMN | 16 | Q4 2019 | 8.8% |
| PTC THERAPEUTICS, INC. CMN | 16 | Q3 2023 | 9.9% |
| EXELIXIS, INC | 16 | Q1 2022 | 7.5% |
| SAGE THERAPEUTICS, INC CMN | 15 | Q3 2021 | 10.8% |
| CYTOKINETICS INC | 15 | Q3 2023 | 5.8% |
| ACADIA PHARMACEUTICALS, INC. | 14 | Q1 2021 | 8.8% |
| ACCELERON PHARMA INC CMN | 14 | Q2 2020 | 8.2% |
| CONNECTURE INC | 13 | Q4 2017 | 25.1% |
View GREAT POINT PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 89bio, Inc. | February 14, 2023 | 700,000 | 1.4% |
| KalVista Pharmaceuticals, Inc. | February 14, 2023 | 1,055,801 | 3.1% |
| Avalo Therapeutics, Inc. | February 13, 2023 | 974,639 | 7.1% |
| InflaRx N.V.Sold out | February 14, 2022 | 0 | 0.0% |
| ABEONA THERAPEUTICS INC.Sold out | February 16, 2021 | 0 | 0.0% |
| CONSTELLATION PHARMACEUTICALS INC | February 16, 2021 | 1,024,800 | 2.2% |
| GERON CORP | February 16, 2021 | 12,754,228 | 4.0% |
| Millendo Therapeutics, Inc. | February 16, 2021 | 270,000 | 1.4% |
| NextCure, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | February 16, 2021 | 977,647 | 2.4% |
View GREAT POINT PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View GREAT POINT PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.